ArticleNature communications2022

A CRISPR-based ultrasensitive assay detects attomolar concentrations of SARS-CoV-2 antibodies in clinical samples.

Yanan Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.